News

MannKind said that Afrezza is a drug-device combination product, consisting of Afrezza inhalation powder pre-metered into single use dose cartridges and the light, discreet and easy-to-use Afrezza Inhaler.

P&G said that the recalling is part of the precautionary step the company is taking after finding that the child-resistant cap does not work in a small percentage

Sanofi-aventis and Metabolex said that GPR119 receptor agonists (or G-protein coupled receptor 119) are known to exert the effects on glucose metabolism by a dual mode of action

TRL started its new operations in May by appointing three new executives, Masaki Yamada as CEO, Toshihiro Hosaka as senior vice president and Roland Newman as VP and

Motavizumab is an investigational humanized monoclonal antibody (MAb) being evaluated for its potential to prevent serious lower respiratory tract disease caused by espiratory syncytial virus (RSV) in pediatric

Basilea Pharmaceutica said that the process to re-open Phase III clinical sites for the Isavuconazole trials has started after the completion of the transfer of the investigational new

Axxess Pharma’s facility is about 22,000sqft and manufactures pharmaceuticals, neutroceuticals and dermotologicals. The company is expected to continue the distribution of its own line of pharmaceuticals from its

Renhuang said that design patents, that are awarded to recognise shape, pattern, or a combination of the two, in an industrial application, are one of three patent categories

Lapatinib, along with an aromatase inhibitor (AI), is suggested for the treatment of post-menopausal women with hormone receptor (HR)-positive, ErbB2 (HER2) over-expressing metastatic breast cancer and for whom